ReviewAntioxidants (Basel, Switzerland)2022

Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases.

Zhenzhen Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.